BMO Capital Markets Increases Hexo (HEXO) Price Target to C$9.00
Hexo (TSE:HEXO) had its price target upped by stock analysts at BMO Capital Markets from C$6.00 to C$9.00 in a report issued on Friday. BMO Capital Markets’ price target would suggest a potential upside of 11.11% from the company’s previous close.
Several other equities research analysts have also recently commented on the company. Jefferies Financial Group reissued an “underperform” rating and issued a C$5.60 price target on shares of Hexo in a research note on Monday, February 25th. CIBC reissued an “outperform” rating and issued a C$8.50 price target on shares of Hexo in a research note on Tuesday, February 19th. Finally, Oppenheimer began coverage on Hexo in a research note on Tuesday, February 19th. They issued an “outperform” rating and a C$7.00 price target for the company.
Shares of TSE HEXO opened at C$8.10 on Friday. The company has a market capitalization of $1.68 billion and a P/E ratio of -38.21. Hexo has a 52 week low of C$3.34 and a 52 week high of C$9.29.
HEXO Corp., through its subsidiary, HEXO Operations Inc, produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names.
Featured Article: What is insider trading?
Receive News & Ratings for Hexo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hexo and related companies with MarketBeat.com's FREE daily email newsletter.